These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22192290)

  • 1. Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(3):448-51. PubMed ID: 22192290
    [No Abstract]   [Full Text] [Related]  

  • 2. Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
    Mori H; Okada Y; Arao T; Nishida K; Tanaka Y
    Adv Ther; 2012 Jul; 29(7):635-44. PubMed ID: 22821644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Apr; 156(1):92-6. PubMed ID: 22192303
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
    Fuke Y; Fujita T; Satomura A; Wada Y; Matsumoto K
    Diabetes Technol Ther; 2010 May; 12(5):393-8. PubMed ID: 20388049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
    Takagi H; Mizuno Y; Yamamoto H; Goto SN; Umemoto T;
    Hypertens Res; 2013 Apr; 36(4):368-73. PubMed ID: 23235712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265
    [No Abstract]   [Full Text] [Related]  

  • 7. Telmisartan reduces triglyceride levels over other angiotensin II receptor blockers: a meta-analysis of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Jun; 157(3):403-7. PubMed ID: 22386702
    [No Abstract]   [Full Text] [Related]  

  • 8. Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.
    Yamada S; Ano N; Toda K; Kitaoka A; Shiono K; Inoue G; Atsuda K; Irie J
    Hypertens Res; 2008 Apr; 31(4):601-6. PubMed ID: 18633170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-gamma activation.
    Moriuchi A; Yamasaki H; Shimamura M; Kita A; Kuwahara H; Fujishima K; Satoh T; Fukushima K; Fukushima T; Hayakawa T; Mizuguchi H; Nagayama Y; Abiru N; Kawasaki E; Eguchi K
    Biochem Biophys Res Commun; 2007 May; 356(4):1024-30. PubMed ID: 17399685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
    Suksomboon N; Poolsup N; Prasit T
    J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?
    Cohn JN
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):526-7. PubMed ID: 18665135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In the DETAIL. Kidney protection in manifestations of microalbuminuria].
    MMW Fortschr Med; 2006 Jun; 148(26):51. PubMed ID: 16875382
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

  • 15. Telmisartan as a metabolic sartan: the first meta-analysis of randomized controlled trials in metabolic syndrome.
    Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
    J Am Soc Hypertens; 2013; 7(3):229-35. PubMed ID: 23523138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients.
    Takagi H; Umemoto T;
    J Am Soc Hypertens; 2014 Aug; 8(8):578-92. PubMed ID: 25151319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.
    Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Aug; 167(4):1443-9. PubMed ID: 22560941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.
    Chetty VT; Damjanovic S; Gerstein H; Singh N; Yusuf S; Anand SS; Sharma AM
    Blood Press; 2014 Feb; 23(1):54-60. PubMed ID: 23731019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
    Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
    J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.